12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

  • Stoke Therapeutics STOK shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. As per the press release, Q4 earnings came out 2 days ago.
  • Lixte Biotechnology LIXT shares rose 43.68% to $3.24. The company's market cap stands at $7.2 million.
  • Nuvation Bio NUVB shares moved upwards by 35.41% to $3.9. The company's market cap stands at $854.2 million.
  • Ontrak OTRK shares moved upwards by 29.18% to $0.55. The market value of their outstanding shares is at $15.2 million.
  • PAVmed PAVM stock increased by 25.72% to $2.59. The market value of their outstanding shares is at $20.8 million. The company's, Q4 earnings came out yesterday.
  • Nutriband NTRB stock rose 24.33% to $3.78. The market value of their outstanding shares is at $31.9 million.

Losers

  • Akili AKLI stock declined by 18.8% to $0.31 during Wednesday's regular session. The company's market cap stands at $24.3 million.
  • Mesoblast MESO shares declined by 12.85% to $3.42. The company's market cap stands at $347.5 million.
  • Salarius Pharmaceuticals SLRX stock fell 11.19% to $0.44. The company's market cap stands at $1.7 million. As per the news, the Q4 earnings report came out 3 days ago.
  • XTL Biopharmaceuticals XTLB shares fell 11.08% to $2.73. The market value of their outstanding shares is at $14.8 million.
  • Fresh2 Group FRES shares declined by 10.6% to $0.57. The market value of their outstanding shares is at $13.5 million.
  • PDS Biotechnology PDSB shares decreased by 9.94% to $4.04. The company's market cap stands at $125.5 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!